Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Euro RSCG Worldwide has won the estimated $100 million global review for Aventis Pharmaceuticals’ Lantus diabetes drug account, sources said.
The Havas agency competed against an initial round of five agencies: Interpublic Group’s McCann-Erickson, Omnicom Group’s TBWA Worldwide, Havas’ Euro RSCG, Grey Global Group’s Healthy Grey and WPP Group’s Young & Rubicam, said sources. Each agency partnered with sister shops that handle media buying and other specialty disciplines.
Late last month after presentations in mid-December, the list of contenders was cut to Healthy Grey, Y&R and Euro RSCG.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in